Today: 8 February 2026
Subscribe
Browse Category

NASDAQ:KALA News 4 December 2025 - 5 December 2025

KALA BIO Stock (NASDAQ: KALA): New $10 Million Offering, Debt Deal and Delisting Risk – December 4, 2025 Update

KALA BIO Stock (NASDAQ: KALA): New $10 Million Offering, Debt Deal and Delisting Risk – December 4, 2025 Update

KALA BIO, Inc. (NASDAQ: KALA) has turned into one of the most volatile biotech penny stocks on the market in late 2025. After a failed eye‑disease trial, a loan default and a near‑miss with foreclosure, the company is now trying to recapitalize itself with fresh equity and new leadership. On December 4, 2025, KALA BIO announced a $10 million registered direct offering of common stock at $1.00 per share, the latest in a series of emergency financings and debt negotiations that have whipsawed KALA stock and left existing shareholders heavily diluted. Finviz+4GlobeNewswire+4GlobeNewswire+4 At the same time, new CEO David E.
5 December 2025
·
KALA BIO (KALA) Stock Explodes on Oxford Deal and $10M Offering: What December 4, 2025 Means for Investors

KALA BIO (KALA) Stock Explodes on Oxford Deal and $10M Offering: What December 4, 2025 Means for Investors

As of December 4, 2025, KALA BIO, Inc. (NASDAQ: KALA) has turned into one of the wildest tickers on the Nasdaq. The stock is trading around $1.40 in heavy volume, up roughly 50% on the day after a cascade of news: a $10 million registered direct offering, a loan settlement that turns lender Oxford Finance into a 16.5% shareholder, and a $6 million rescue-style preferred investment from new CEO David Lazar. All this arrives barely two months after KALA’s lead drug failed a key trial, its lender swept most of its cash, and management warned of “substantial doubt” about its
4 December 2025
·

Stock Market Today

SMIC stock set for results test this week as Hong Kong market reopens

SMIC stock set for results test this week as Hong Kong market reopens

8 February 2026
HONG KONG, Feb 8, 2026, 08:40 HKT — Market closed Semiconductor Manufacturing International Corp’s Hong Kong-listed shares ended Friday little changed, but the stock heads into a catalyst-heavy week with results due and a shareholder vote on a deal that would simplify control of a key 12-inch wafer unit. (Reuters) The next test comes quickly. SMIC’s board meets on Tuesday, Feb. 10, when the company said it will announce unaudited financial results. (HKEX News) Two days later, investors get a second lever: an extraordinary general meeting in Shanghai on Feb. 12. Trading in the name often tightens ahead of corporate
MediaTek stock price drops 3.4% as Taiwan market shuts; what investors watch next week

MediaTek stock price drops 3.4% as Taiwan market shuts; what investors watch next week

8 February 2026
MediaTek shares closed down 3.4% at NT$1,710 on Friday in Taipei, with 11.8 million shares traded before the market shut for the weekend. The company said it will double investment in data-center chips and advanced packaging, while warning of rising supply chain costs. Fourth-quarter sales rose 8.8% to NT$150.2 billion, but net income slipped 3.6%. Investors face uncertainty ahead of the Lunar New Year break and a weaker tech sector mood.
Arm Holdings stock rallies into weekend on AI spending hopes — Monday’s next test

Arm Holdings stock rallies into weekend on AI spending hopes — Monday’s next test

8 February 2026
Arm Holdings’ U.S. shares jumped 11.6% Friday to $123.70, capping an 18% two-day rebound amid a rally in chip stocks tied to AI data-center spending. The gains followed Arm’s fiscal Q3 revenue beat, but executives warned memory shortages could cut royalty revenue by up to 2% as smartphone chip shipments are expected to fall 7% in 2026. Investors now await Arm’s “Arm Everywhere” event on March 24.
Go toTop